Hillsdale Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Hillsdale Investment Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-133,960	Closed	-$5.31M	–	719
2024 Q1	$5.31M	Buy	+133,960	New	+$3.95M	0.42%	57

Hillsdale Investment Management's ALPN Position: Q2 2024 in Review

Hillsdale Investment Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 133,960 shares — an estimated $5.31M sold.

Hillsdale Investment Management first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $5.31M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Hillsdale Investment Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Hillsdale Investment Management sold 133,960 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $5.31M.
Hillsdale Investment Management first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Hillsdale Investment Management's Alpine Immune Sciences Inc position peaked at $5.31M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Hillsdale Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.